HKEX Stock Code: 01093English|繁體|简体

For 2020 Interim Results

  • Sales of approximately RMB12,590 million, representing a 12.6% growth year-on-year;
  • Profit attributable to shareholders of approximately RMB2,314 million, representing a 23.2% growth year-on-year.

Highlight - 2020 Interim Results

Revenue
RMB12,590mn, +12.6%
Profit attributable to shareholders
RMB2,314mn, +23.2%
Basic earnings per share
RMB30.97 cents, +23.3%

Corporate Governance

Corporate Governance

Financial Calendar

Nov
23
Nov
23
Aug
26
Aug
26
Jun
15
May
27
May
27
Mar
30
Mar
30

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2020 CSPC Pharmaceutical Group Limited. All Rights Reserved.